Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Lymphomas of the head and neck region: an update

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Diabetes i familien – familien og diabetes

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  2. Diabetespatienter er afhængige af et løft af det nære sundhedsvæsen

    Publikation: AndetUdgivelser på nettet - Net-publikationFormidling

  3. Forord

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiFormidling

  4. Kun gode relationer kan nedbryde ’Sundhedsvæsnets Bermudatrekant’

    Publikation: Bidrag til tidsskriftBidrag til avis - Kommentar/debatFormidling

  • Camilla Birch Nielsen
  • Søren Krag
  • Ruth ØSterby
  • Allan Flyvbjerg
  • Jens Nyengaard
  • Axel Forman
  • Lise Wogensen
Vis graf over relationer

Transforming growth factor beta1 (TGF-beta1) affects extracellular matrix (ECM) accumulation. It plays a role in the thickening of the peripheral basement membrane (PBM) and expansion of the mesangium in several renal diseases. The beneficial influence of female gender on the progression of chronic renal diseases may be explained by a favorable effect of estrogen on ECM homeostasis. Interactions between TGF-beta1 and estrogen have been investigated in mesangial cell cultures. However, it is unknown if TGF-beta1-induced glomerulopathy in vivo is influenced by exogenous estrogen. Thus, the aim of the present experiment was to explore whether estrogen prevents the development of TGF-beta1-induced glomerular disease in transgenic mice expressing active TGF-beta1 under control of the Ren-1c promoter. Mice were treated from 3 weeks to 6 weeks of age with 17beta-estradiol release pellets (5-10 microg/kg body weight per day). At the age of 6 weeks, all investigated animals were sacrificed for estimation of PBM thickness, the mesangium per glomerulus [Vv(mes/glom)], the mesangial matrix per glomerulus [Vv(matrix/glom)] and the PBM per glomerulus [Vv(PBM/glom)] using electron microscopy and stereological methods. Furthermore, the total collagen content was determined. We found that TGF-beta1-induced alterations in Vv(mes/glom), Vv(matrix/glom) and Vv(PBM/glom) were prevented in mice exposed to exogenous 17beta-estradiol. In addition, the interstitial fibrosis that develops in TGF-beta1 transgenic mice was attenuated by administration of 17beta-estradiol. In conclusion, estrogen may oppress TGF-beta1-mediated kidney diseases and, thereby, contribute to the protracted development of end-stage renal disease in pre-menopausal women.

TidsskriftVirchows Archiv : an international journal of pathology
Udgave nummer6
Sider (fra-til)561-6
Antal sider6
StatusUdgivet - jun. 2004
Eksternt udgivetJa

ID: 51976784